Here's how two local biotechs plan to have a coronavirus vaccine within just a few months

Young startups Moderna and CureVac, neither of which has brought a drug to market before, believe they can differentiate themselves from their competitors thanks to an experimental approach involving messenger RNA.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.